Haiti National Program for the Elimination of Lymphatic Filariasis-A Model of Success in the Face of Adversity

PLoS Neglected Tropical Diseases

Volumn 8, Issue 7, 2014, Pages

  Oscar, Roland ^a   Lemoine, Jean Frantz ^a   Direny, Abdel Nasser ^b,c   Desir, Luccene ^c,d   Beau de Rochars, Valery E Madsen ^c,d,e   Poirier, Mathieu J P ^d   Varghese, Ann ^c   Obidegwu, Ijeoma ^f   Lammie, Patrick J ^e   Streit, Thomas G ^c,d   de Milord, Marienise ^a,d  

^a Ministry of Public Health and Population   (Haïti)

^b IMA World Health   (United States)

^c Hopital Ste Croix ^*  (Haïti)

^d UNIVERSITY OF NOTRE DAME   (United States)

^e CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^f CBM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALBENDAZOLE; DIETHYLCARBAMAZINE;

ARTICLE; CULEX; EARTHQUAKE; ELEPHANTIASIS; FLOODING; FUNDING; HEALTH PROGRAM; HELMINTHIASIS; HUMAN; IMMUNOAFFINITY CHROMATOGRAPHY; LYMPHATIC FILARIASIS; LYMPHEDEMA; MORBIDITY; NATURAL DISASTER; PARASITE CLEARANCE; TRAINING; VECTOR CONTROL;

EID: 84905511539     PISSN: 19352727     EISSN: 19352735     Source Type: Journal    
DOI: 10.1371/journal.pntd.0002915     Document Type: Article

References (32)

1. Coreil J, Mayard G, Louis-Charles J, Addiss D, (1998) Filarial elephantiasis among Haitian women: social context and behavioural factors in treatment. Trop Med Int Health 3: 467-473.
2. Person B, Addiss D, Bartholomew LK, Meijer C, Pou V, et al. (2008) "Can it be that God does not remember me": a qualitative study on the psychological distress, suffering, and coping of Dominican women with chronic filarial lymphedema and elephantiasis of the leg. Health Care Women Int 29: 349-365.
3. WHO (2010) Global Programme to Eliminate Lympathic Filariasis. Wkly Epidemiol Rec 85: 365-372.
4. Galvez Tan JZ, (2003) The elimination of lymphatic filariasis: A strategy for poverty alleviation and sustainable development- Perspectives from the Philippines. Filaria J 2: 12.
5. WHO (2007) Global Programme to Eliminate Lympathic Filariasis. Wkly Epidemiol Rec 82: 361-380.
6. Raccurt C, Hodges W, Boncy J, (1983) [Lymphatic filariasis in Haiti. Results of treatment with diethylcarbamazine in the town of Limbe]. Bull Soc Pathol Exot Filiales 76: 172-177.
7. Raccurt CP, (1999) [Filariasis in Haiti: a century of history]. Bull Soc Pathol Exot 92: 355-359.
8. Beau de Rochars MV, Milord MD, St Jean Y, Desormeaux AM, Dorvil JJ, et al. (2004) Geographic distribution of lymphatic filariasis in Haiti. Am J Trop Med Hyg 71: 598-601.
9. WHO (2000) Preparing and implementing a national plan to eliminate lymphatic filariasis. WHO/CDS/CPE/CEE/2000.15. Available: http://whqlibdoc.who.int/hq/2000/who_cds_cpe_cee_2000.15.pdf. Accessed 17 June 2014.
10. Drexler N, Washington CH, Lovegrove M, Grady C, Milord MD, et al. (2012) Secondary mapping of lymphatic filariasis in Haiti-definition of transmission foci in low-prevalence settings. PLoS Negl Trop Dis 6: e1807 doi:10.1371/journal.pntd.0001807.
11. Beau de Rochars M, Kanjilal S, Direny AD, Radday J, Lafontant JG, et al. (2005) The Léogâne, Haiti demonstration project: decreased microfilaremia and program costs after three years of mass drug administration. Am J Trop Med Hyg 73: 888-894.
12. Grady CA, Beau de Rochars M, Direny AN, Orelus JN, Wendt J, et al. (2007) Endpoints for lymphatic filariasis programs. Emerg Inf Dis 13: 608-610.
13. Mathieu E, Lammie PJ, Radday J, Beach MJ, Streit T, et al. (2004) Factors associated with participation in a campaign of mass treatment against lymphatic filariasis, in Léogâne, Haiti. Ann Trop Med Parasitol 98: 703-714.
14. McLaughlin SI, Radday J, Michel MC, Addiss DG, Beach MJ, et al. (2003) Frequency, severity, and costs of adverse reactions following mass treatment for lymphatic filariasis using diethylcarbamazine and albendazole in Léogâne, Haiti, 2000. Am J Trop Med Hyg 68: 568-573.
15. Mathieu E, Deming M, Lammie PJ, McLaughlin SI, Beach MJ, et al. (2003) Comparison of methods for estimating drug coverage for filariasis elimination, Leogane Commune, Haiti. Trans Roy Soc Trop Med Hyg 97: 501-505.
16. Worrell C, Mathieu E, (2012) Drug coverage surveys for neglected tropical diseases: 10 years of field experience. Am J Trop Med Hyg 87: 216-222.
17. Won KY, Beau de Rochars M, Kyelem D, Streit TG, Lammie PJ, (2009) Assessing the impact of a missed MDA in Haiti. PLoS Negl Trop Dis 3: e443 doi:10.1371/journal.pntd.0000443.
18. Champetier de Ribes G, Fline M, Desormeaux AM, Eyma E, Champagne C, et al. (2005) [Intestinal helminthiasis in school children in Haiti in 2002]. Bull Soc Pathol Exot 98: 127-132.
19. Beau de Rochars M, Direny AD, Roberts JM, Addiss DG, Radday J, et al. (2004) Community-wide reduction in prevalence and intensity of intestinal helminths as a collateral benefit of lymphatic filariasis elimination programs. Am J Trop Med Hyg 71: 466-470.
20. Goldman AS, Brady MA, Direny A, Desir L, Oscar R, et al. (2011) Costs of integrated mass drug administration for neglected tropical diseases in Haiti. Am J Trop Med Hyg 85: 826-833.
21. Centers for Disease Control and Prevention (2010) Update: cholera outbreak-Haiti, 2010. MMWR 59: 1473-1479.
22. Centers for Disease Control and Prevention (2013) Mass Drug Administration for the Elimination of Lymphatic Filariasis - Port-au-Prince, Haiti, 2011-2012. MMWR 62: 466-468.
23. Talbot JT, Viall A, Direny A, de Rochars MB, Addiss D, et al. (2008) Predictors of compliance in mass drug administration for the treatment and prevention of lymphatic filariasis in Léogâne, Haiti. Am J Trop Med Hyg 78: 283-288.
24. Boyd A, Won KY, McClintock SK, Donovan CV, Laney SJ, et al. (2010) Factors associated with continuing transmission of lymphatic filariasis in Léogâne, Haiti. PLoS Negl Trop Dis 4: e640 doi:10.1371/journal.pntd.0000640.
25. Cantey PT, Rout J, Rao G, Williamson J, Fox LM, (2010) Increasing compliance with mass drug administration programs for lymphatic filariasis in India through education and lymphedema management programs. PLoS Negl Trop Dis 4: e728 doi:10.1371/journal.pntd.000072.
26. Dembele B, Coulibaly YI, Dolo H, Konate S, Coulibaly SY, et al. (2010) Use of high-dose, twice-yearly albendazole and ivermectin to suppress Wuchereria bancrofti microfilarial levels. Clin Infect Dis 51: 1229-1235.
27. Houston R, (2000) Salt fortified with diethylcarbamazine (DEC) as an effective intervention for lymphatic filariasis, with lessons learned from salt iodization programmes. Parasitology 121 (Suppl) S161-S173.
28. Lammie P, Milner T, Houston R, (2007) Unfulfilled potential: using diethylcarbamazine-fortified salt to eliminate lymphatic filariasis. Bull World Health Organ 85: 545-549.
29. Freeman AR, Lammie PJ, Houston R, Jooste PL, Lapointe MD, et al. (2001) A community-based trial for the control of lymphatic filariasis and iodine deficiency using salt fortified with diethylcarbamazine and iodine. Am J Trop Med Hyg 65: 865-871.
30. WHO (2008) Meeting of the International Taskforce for Disease Eradication- 11 October 2007. Wkly Epidemiol Rec 83: 77-88.
31. Addiss DG, Louis-Charles J, Roberts J, LeConte F, Wendt JM, et al. (2010) Feasibility and effectiveness of basic lymphedema management in Leogane, Haiti, an area endemic for Bancroftian filariasis. PLoS Negl Trop Dis 4: e668 doi:10.1371/journal.pntd.0000668.
32. Norões J, Dreyer G, (2010) A mechanism for chronic filarial hydrocele with implications for its surgical repair. PLoS Negl Trop Dis 4: e695 doi:10.1371/journal.pntd.0000695.